CN100516217C - Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa - Google Patents
Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa Download PDFInfo
- Publication number
- CN100516217C CN100516217C CNB2004100125446A CN200410012544A CN100516217C CN 100516217 C CN100516217 C CN 100516217C CN B2004100125446 A CNB2004100125446 A CN B2004100125446A CN 200410012544 A CN200410012544 A CN 200410012544A CN 100516217 C CN100516217 C CN 100516217C
- Authority
- CN
- China
- Prior art keywords
- rbmk
- cta
- scorpion
- gene
- tgc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention makes 24-site mutation on natural scorpion chlorine ion channel neurotoxin gene BmK CT according to the principle of Escherichia coli partial to codon, designs DNA sequence suitable to be expressed in Escherichia coli BL21 (DE3), adopts PCR technique to complete artificial synthesis of recombinant scorpion chlorine ion channel neurotoxin gene rBmK CTa. On this basis, it clones rBmK CTa into pEXSecI expression system to transfer in the BL21 (DE3), screens and obtains high-performance expressed bacterial strain, detects that the expressed product of the rBmK CTa accounts for 19.936% of the all-bacterium protein by SDS-PAGE electrophoresis, and by affinity chromatography, obtains purer protein with bioactivity, and can obtain 2.4mg protein from one liter culture liquor by purifying. The obtained modified recombinant scorpion chlorine ion channel neurotoxin has inhibition effect on neuroglia cell and can be used in preparing medicines curing diseases by inhibiting neuroglia cell and also be used in research on the space structure and pharmacological activity of scorpion neurotoxin.
Description
Technical field
The present invention relates to sudden change and genetic engineering, specifically belong to the DNA recombinant technology, scorpion chloride channel neurotoxin gene rBmK CTa and this expression of gene thereof of a kind of improvement of saying so more specifically.
Background technology:
The China scorpion has 15 kinds approximately, and the widest, the maximum persons of quantity of wherein distributing are buthus martensii Karscs (Buthus martensii).In China, since 1981, the research of buthus martensii Karscs some progress have been obtained.Purifying the part scorpion toxin, measure the part primary structure, studied the influence of pharmacology and physiological action and cell membrane, also from scorpion venom, be purified to many higher antiepileptic activity polypeptide (Anti-epilepsy peptide that have, AEP) (Wang, C.G., European Journal ofBiochemistry, 2001,268:2480).
Neurogliocyte is the cell that canceration easily takes place in the human brain.Neuroglial cytoma is celebrated with extensive various histological characteristic with high diffusibility.In recent years many discovering shows that the chloride channel toxin that extracts can effectively prevent diffusion (Deshhane, J. etc., J.Biol.Chem.2003,278 (6): 4135-4144) of neuroglial cytoma by a kind of approach from buthus martensii Karscs.First chloride channel toxin gene Bm-12 is by Wu, J. wait the clone to obtain (Toxicon, 2000,38:661-668), meanwhile, the domestic Zeng of another seminar, (Toxicon such as X.C., 2000,38:1009-1014) also from the cDNA library of buthus martensii Karscs tail gland, obtain this gene, and called after BmK CT.This section led the chloride channel inhibitor protein by 35 amino acid, the four pairs of disulfide linkage small peptide of forming and the little electricity that extracts from Israel scorpion L.quinquestriatus scorpion homology is 66%.How this small peptide optionally combines with chloride channel and have an effect awaits further research.
Just because of specific activity and the high selectivity that the scorpion neurotoxin is had, it has been applied to as important instrument increasingly extensively, and mediator in the evaluation of the relevant target ion channel protein composition that relates in the neural bio-science and purifying, toxin and acceptor site bonded specificity and susceptibility and the receptor modulators born of the same parents discharges and the fundamental research of the biological phenomenas such as molecular mechanism of information transmission.On the other hand, they are also just demonstrating very tempting application prospect as the newtype drug in future.
But from the thick poison of scorpion, extract not only complex steps of single pure protein, and amount is few, can not satisfies scientific research and the medical needs of producing far away,, also do not have to obtain in a large number at present the effective way of its pure protein especially to those poor toxin in natural thick scorpion venom.The present invention adopts round pcr and genetic engineering technique, can obtain a large amount of purer chloride channel scorpion toxins.Not only for traditional Chinese medicine provides competent source with the scorpion venom pharmacy, but also can be used for the research such as toxicology, pharmacology of neurochemistry, protein chemistry, scorpion venom.
Summary of the invention:
The present invention is according to the sequence (Zeng of the natural scorpion chloride channel neurotoxin of having reported, X.C. wait Toxicon, 2000,38:1009-1014), designed the dna sequence dna that is adapted in the colibacillus expressing this gene, and in intestinal bacteria the great expression rBmK CTa.
1, gene order:
According to purpose of the present invention, a kind of scorpion chloride channel neurotoxin gene rBmK CTa of improvement is provided, its nucleotides sequence is classified as:
ATG?TG
GG
CC
TGC?TT
AC
AC
GA
GCT?AA
ATG?GC
AG
AAA?TG
AG
GAA?TG
TG
GG
GGT?AT
GG
AAA?TGC?TT
GG
CC
CA
TG
CTGTG
AAC?CGT?AT
TGA
(wherein the base in the square frame is for designing according to the intestinal bacteria preference codon, and original series is seen accompanying drawing 1A)
2, obtain the method for this gene order:
The invention provides the synthetic method of a kind of rBmK CTa gene rBmK CTa in addition, comprise step:
I. design 6 dna oligo sequences (seeing accompanying drawing 1C);
II. the synthetic scorpion chloride channel neurotoxin gene of artificial bypass method-rBmK CTa;
At first synthetic a series of dna oligo in the above-mentioned steps, wherein said dna oligo is 2 forward sequences, 2 is reverse sequence; 2 is the joint primer, has EcoRI and BamHI restriction enzyme site respectively.
Adopt polymerase chain reaction (PCR) technology to carry out the artificial bypass method synthetic (seeing accompanying drawing 2) of this gene.Dna sequence analysis is confirmed the exactness (seeing accompanying drawing 3) of this synthetic gene.
3, the expression of rBmK CTa, purification process:
The present invention also provides a kind of expression method of rBmK CTa, and its step comprises:
I. synthetic scorpion chloride channel neurotoxin gene rBmK CTa is cloned in the expression vector;
Ii uses the heat-shocked method with in this recombinant plasmid transformed host cell;
Iii. screening obtains transforming bacterial strain;
Iv. abduction delivering goes out rBmK CTa.
Above-mentioned artificial bypass method synthetic rBmK CTa gene rBmK CTa is cloned among the expression vector prokaryotic expression carrier pExSecI, obtains recombinant expression plasmid pExSecI-rBmK CTa (seeing accompanying drawing 4).With the heat-shocked method with this recombinant plasmid transformed host cell e. coli bl21 (DE3), screening obtains transforming bacterial strain, induces with IPTG that (in the present embodiment, inductive condition is 0.4mM IPTG, induced 4 hours for 16 ℃), the expression product of acquisition rBmK CTa.Extract its total protein, through denaturing polyacrylamide gel electrophoresis (SDS-PAGE) and glue figure scan gray analysis (GeneTools software, U.S.A) after, analyze the percentage composition that this expressing quantity accounts for bacterial protein.RBmK CTa gene expression product accounts for 19.936% of e. coli total protein, also comprise purification step, but purifying obtains this recombinant protein of 2.4mg from one liter of nutrient solution, and the expression amount of crt gene BmK CT only is 9.116% (to see accompanying drawing 5,6), show that the scorpion chloride channel neurotoxin gene rBmK CTa after the improvement compares in the raising of expression in escherichia coli amount more than 50% with original gene BmKCT.
The purification step of rBmK CTa mainly is that the above-mentioned total protein that abduction delivering goes out in intestinal bacteria is crossed IgG Sepharose 6 Fast Flow affinity columns, obtain pure protein and, show that gained albumen is scorpion chloride channel neurotoxin through Western blot identification and analysis.
4, the purposes of rBmK CTa expression product:
Utilize inhibited to neurogliocyte of rBmK CTa that the present invention obtains.Can be used for preparing, also can be used for researchs such as scorpion neurotoxin space structure and pharmacological activity by suppressing the medicine of the treatable disease of neurogliocyte.
Activity to neurogliocyte in the invention process detects the employing mtt assay, will be from the neurogliocyte of suckling mouse brain extraction, add in 96 well culture plates, rBmK CTa with different protein concentration gradients is handled, after in incubator, cultivating, (3-(4 to add MTT, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide), cultivation is placed on the absorption value of measuring the 490nm place in the microplate reader, and the method for calculation of inhibiting rate are: 1-(treatment group OD
490/ untreated fish group OD
490).Utilize be inhibited rate and handle regression curve between the protein concentration of Sigma blot software.Embodiment 4 is seen in concrete operations, and what record partly suppresses dosage (IC
50) be 45 μ M.
Description of drawings:
Accompanying drawing 1A: former BmK CT gene order (Zeng, Toxicon such as X.C., 2000,38:1009-1014):;
Accompanying drawing 1B: according to intestinal bacteria preference codon principle, rBmK CTa gene order and aminoacid sequence that 24 site mutations are formed;
Accompanying drawing 1C: 6 primer sequences of design.
Accompanying drawing 2: bypass method synthesizes rBmK CTa gene synoptic diagram.
Accompanying drawing 3:rBmK CTa sequencer address result.
Accompanying drawing 4:pExSecI-rBmK CTa construction of recombinant plasmid figure.
Accompanying drawing 5:rBmK CTa gene expression product SDS-PAGE analysis chart and gray scale scanning analysis chart.
Accompanying drawing 6:rBmK CTa gene expression product gray scale scanning analysis chart.
Proteic purification result of accompanying drawing 7:rBmK CTa and Western blot identify.
Accompanying drawing 8:rBmK CTa albumen is to the inhibition activity identification graphic representation of neurogliocyte.
Embodiment:
The synthetic of embodiment 1, improvement gene
Sequence (seeing Fig. 1 C) according to synthetic 6 dna oligos of natural B mK CT gene.Wherein Primer1,2 is a forward primer, and Primer3,4 is a reverse primer, and BmK CT (EcoRI), BmKCT (BamHI) are two end connector primers, have EcoRI, BamHI restriction enzyme site respectively, so that be connected with the pExSecI expression system.
Make PCR respectively with Primer 1 and 3,2 and 4, after two products are carried out terminal smoothing.Mix back PCR and obtain the rBmK-CTa gene.It is cloned among the pGEM-T Easy order-checking (seeing Fig. 2,3).
With primer BmK CT (EcoRI), BmKCT (BamHI) amplification rBmK-CTa gene, cut with EcoRI, BamHI enzyme then, be connected (see figure 4) with the expression vector pExSecI that cuts through same enzyme.
Abduction delivering and the purifying of embodiment 3, rBmK CTa rBmK CTa
Recombinant plasmid pExSecI-rBmK CTa transformed into escherichia coli BL21 (DE3), through 0.4mM IPTG, induced 4 hours for 16 ℃, the SDS-PAGE electrophoresis detection is to the great expression of this gene, account for 19.936% of whole bacterial protein, and the expression amount of crt gene BmK CT only is 9.116% (seeing accompanying drawing 5,6), shows that the scorpion chloride channel neurotoxin gene rBmK CTa after the improvement compares in the raising of expression in escherichia coli amount more than 50% with original gene BmK CT.
Through IgG-Sepharose 6 Fast Flow (Pharmacia biotech, Sweden) affinity chromatography obtains than pure protein, but purifying obtains this albumen of 2.4mg (seeing Fig. 7 A) from one liter of nutrient solution.Western blot is accredited as rBmK CTa gene expression product (seeing Fig. 7 B).Antibody is scorpion venom total protein antibody.
RBmK CTa albumen suppresses active test experience to neurogliocyte and adopts mtt assay, and detailed process is as follows: (damping fluid is a liquid outside the standard cell lines to the neurogliocyte that will extract from the suckling mouse brain, ES) by every hole 5 * 10
4Individual cell adds in 96 well culture plates, to handle to the protein concentration gradient of 240 μ M from 0.24 μ M, at 37 ℃ CO
2Cultivate after 24 hours in the incubator, (3-(4 for the MTT of adding 5mg/ml, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 15 μ l, cultivate and be placed on microplate reader in 4 hours (BIO-RAD 550, U.S.A) measure the absorption value at 490nm place in, the method for calculation of inhibiting rate are: 1-(treatment group OD
490/ untreated fish group OD
490).Utilize be inhibited rate and handle regression curve between the protein concentration of Sigmablot software.
The active rBmK CTa albumen that shows expression and purification that detects has neurogliocyte and suppresses active, and what record partly suppresses dosage (IC
50) be 45 μ M (see figure 8)s.
Nucleotide and aminoacid sequence table
＜110〉University Of Shanxi
＜120〉a kind of scorpion chloride channel neurotoxin gene-rBmK CTa of synthetic
<160>2
<210>1
<211>111
<212>DNA
＜213〉buthus martensii Karscs (Buthus martensii Karsch)
＜223〉n=a or g or c or t
<221>CDS
<222>(1)...(111)
<400>1
atg?tgc?ggt?ccg?tgc?ttc?act?act?gac?gct?aac?atg?gct?aga?aaa?tgc 48
Met?Cys?Gly?Pro?Cys?Phe?Thr?Thr?Asp?Ala?Asn?Met?Ala?Arg?Lys?Cys
1 5 10 15
aga?gaa?tgc?tgt?ggt?ggt?atc?ggt?aaa?tgc?ttc?ggt?ccg?cag?tgc?ctg 96
Arg?Glu?Cys?Cys?Gly?Gly?Ile?Gly?Lys?Cys?Phe?Gly?Pro?Gln?Cys?Leu
20 25 30
tgc?aac?cgt?atc?tga 111
Cys?Asn?Arg?Ile?***
35
<210>2
<211>36
<212>PRT
＜213〉buthus martensii Karscs (Buthus martensii Karsch)
<400>2
Met?Cys?Gly?Pro?Cys?Phe?Thr?Thr?Asp?Ala?Asn?Met?Ala?Arg?Lys?Cys
1 5 10 15
Arg?Glu?Cys?Cys?Gly?Gly?Ile?Gly?Lys?Cys?Phe?Gly?Pro?Gln?Cys?Leu
20 25 30
Cys?Asn?Arg?Ile?***
35
Claims (7)
1, a kind of scorpion chloride channel neurotoxin gene rBmK CTa of improvement, its nucleotides sequence is classified as:
ATG?TGC?GGT?CCG?TGC?TTC?ACT?ACT?GAC?GCT?AAC?ATG?GCT?AGA?AAA?TGC
AGA?GAA?TGC?TGT?GGT?GGT?ATC?GGT?AAA?TGC?TTC?GGT?CCG?CAG?TGC?CTG?TGC
AAC?CGT?ATC?TGA
2, the synthetic method of the described gene of claim 1:
I. design 6 dna oligo sequences;
Ii. adopt the polymerase chain reaction technology to carry out the synthetic scorpion chloride channel neurotoxin gene of artificial bypass method-rBmK Cta.
3, the method for claim 2, wherein said dna oligo are 2 forward sequences, and 2 is reverse sequence; 2 is the joint primer, has EcoRI and BamHI restriction enzyme site respectively.
4, a kind of expression method of rBmK CTa, its step comprises:
I. the described scorpion chloride channel of claim 1 neurotoxin gene rBmK CTa is cloned in the expression vector;
Ii. use the heat-shocked method with in this recombinant plasmid transformed host cell;
Iii. screening obtains transforming bacterial strain;
Iv. abduction delivering goes out rBmK CTa.
5, the method for claim 4 also comprises the purification step of rBmK CTa.
6, the method for claim 5, described purifying were IgG Sepharose 6 Fast Flow affinity columns.
7, the method for claim 4, described carrier is pExSecI, as shown in Figure 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100125446A CN100516217C (en) | 2004-09-22 | 2004-09-22 | Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100125446A CN100516217C (en) | 2004-09-22 | 2004-09-22 | Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1597951A CN1597951A (en) | 2005-03-23 |
| CN100516217C true CN100516217C (en) | 2009-07-22 |
Family
ID=34662863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100125446A Expired - Fee Related CN100516217C (en) | 2004-09-22 | 2004-09-22 | Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100516217C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100447245C (en) * | 2005-12-23 | 2008-12-31 | 上海大学 | Sodium-channel modulator Bmk a IV gene and its clonal and recombinant-protein expression |
| CN104974236B (en) * | 2015-07-15 | 2018-08-28 | 广州市第一人民医院 | A kind of Buthotoxin polypeptide B4 and its isolation and purification method and application |
| CN106220713B (en) * | 2016-08-08 | 2017-09-01 | 大连医科大学 | A kind of heat-resisting synthetic peptide of scorpion venom and application thereof |
| CN106636118A (en) * | 2016-12-19 | 2017-05-10 | 怀化学院 | Scorpion neurotoxin AaIT and encoding gene and application thereof |
| CN106754942A (en) * | 2016-12-19 | 2017-05-31 | 怀化学院 | The preparation method of scorpion neurotoxin AaIT recombinations and its albumen and application |
-
2004
- 2004-09-22 CN CNB2004100125446A patent/CN100516217C/en not_active Expired - Fee Related
Non-Patent Citations (5)
| Title |
|---|
| Cloning and characterization of the cDNAsequencesencoding the precursor of a chlorotoxin-likepeptide from theChinese sorpion Buthus martensii Karsch. Xian-Chun, Zeng et al.Toxicon,Vol.38 . 2000 |
| Cloning and characterization of the cDNAsequencesencoding the precursor of a chlorotoxin-likepeptide from theChinese sorpion Buthus martensii Karsch. Xian-Chun, Zeng et al.Toxicon,Vol.38. 2000 * |
| 东亚钳蝎神经毒素基因BmKCT的克隆与表达. 张守涛，郭霭光，肖乐义，董建军，赵天增，薛歧庚，孔天翰，郭唯.西北农林科技大学学报(自然科学版)，第30卷第6期. 2002 |
| 东亚钳蝎神经毒素基因BmKCT的克隆与表达. 张守涛，郭霭光，肖乐义，董建军，赵天增，薛歧庚，孔天翰，郭唯.西北农林科技大学学报(自然科学版)，第30卷第6期. 2002 * |
| 两个东亚钳蝎神经毒素cDNA的克隆和序列分析 . 朱顺义，李文鑫，曾宪春，蒋达和，毛歆.武汉大学学报(自然科学版)，第46卷第4期. 2000 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1597951A (en) | 2005-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108912221A (en) | For producing auxilin, encoding gene, recombination fusion protein, recombinant expression carrier and the preparation method of recombination fusion protein | |
| CN110643612B (en) | Trachinotus ovatus antimicrobial peptide NK-lysin gene and application thereof | |
| Bruce et al. | Recombinant conotoxin, TxVIA, produced in yeast has insecticidal activity | |
| CN106967659A (en) | A kind of structure and fermentation process of the antibiotic-free resistance recombined bacillus subtilis for expressing glutamate decarboxylase | |
| CN110551732A (en) | Trachinotus ovatus antimicrobial peptide LEAP-2 gene and application thereof | |
| Jiang et al. | Identification of a novel O-conotoxin reveals an unusual and potent inhibitor of the human α9α10 nicotinic acetylcholine receptor | |
| CN107056925A (en) | People FGF21 mutant, preparation method and the usage | |
| CN101302526A (en) | Recombinant soluble streptococcus hemolyticus haemolysin O gene, recombinant protein and preparation thereof | |
| CN100516217C (en) | Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa | |
| Zhu et al. | Recombinant expression and characterization of α-Conotoxin LvIA in Escherichia coli | |
| Tanoeyadi et al. | Acarbose may function as a competitive exclusion agent for the producing bacteria | |
| Masuyer | Crystal structure of exotoxin A from aeromonas Pathogenic Species | |
| CN107226850B (en) | Polypeptide for inhibiting activity of alpha glycosidase and application thereof | |
| CN109627316A (en) | Recombinant protein and the application of 2 gene of grass carp IFN-γ and its coding | |
| Li et al. | The expression, purification and crystallization of a ubiquitin-conjugating enzyme E2 from Agrocybe aegerita underscore the impact of His-tag location on recombinant protein properties | |
| Ehlert et al. | Limited and Defined Truncation at the C Terminus Enhances Receptor Binding and Degranulation Activity of the Neutrophil-activating Peptide 2 (NAP-2): COMPARISON OF NATIVE AND RECOMBINANT NAP-2 VARIANTS (∗) | |
| CN104694558B (en) | A kind of esterase gene estZ and its coding protein and application | |
| CN101497863B (en) | Method for preparing N-terminated acetylated thymosin alpha 1 and special engineering bacteria therefor | |
| CN103397038B (en) | Production method of human interleukin-38 | |
| CN1416472A (en) | High expression and prodn. of high-specific activity recombinant s-adenosyl homocysteinase (SAHH)and improved assays for s-adenosylmethionine (SAM) | |
| CN109053896A (en) | A kind of pig circular ring virus bivalent genetic engineering vaccine | |
| CN104480126A (en) | Trachinotus ovatus peroxiredoxin gene | |
| Shoja et al. | Cloning and expression of Beta Subunit Gene of Phycocyanin from Spirulina platensis in Escherichia coli | |
| CN108277210A (en) | Mould ketenes hydrolase ZEN214 and encoding gene and application | |
| CN100465272C (en) | Genetic engineering for recombining scorpion venom rBmKaIT1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090722 Termination date: 20091022 |